4processed
Form 4 — Insider Transaction
KalVista Pharmaceuticals, Inc.(KALV)
Filing Date
June 11, 2026
Accepted
June 11, 2026
Accession No.
0001827505-26-000007
CIK
0001348911
Insider Transactions
| Insider | Title | Type | Shares | Price | Value | Owned After | Security | Date |
|---|---|---|---|---|---|---|---|---|
| Sweeny Nicole | Chief Commercial Officer | Other | 59.3K | $0 | — | 0 | Common Stock | Jun 11, 2026 |
| Sweeny Nicole | Chief Commercial Officer | Other | 100.0K | — | — | 0 | Stock Option (Right to Buy) | Jun 11, 2026 |
| Sweeny Nicole | Chief Commercial Officer | Other | 40.0K | — | — | 0 | Restricted Stock Unit | Jun 11, 2026 |
| Sweeny Nicole | Chief Commercial Officer | Other | 68.8K | — | — | 0 | Restricted Stock Unit | Jun 11, 2026 |
| Sweeny Nicole | Chief Commercial Officer | Other | 93.8K | — | — | 0 | Restricted Stock Unit | Jun 11, 2026 |